Utah’s AI prescribing program tries to solve a legitimate problem, but eliminating the doctor from certain clinical decisions ...
Northwestern and Scripps Health join two previously announced sites in achieving this critical patient enrollment milestone Seven leading U.S.
Quarterly Nociscan scan volumes increased 114% year-over-year in Q4 2025Annual Nociscan scan volumes increased 69% ...
As women’s health gains attention, institutional credibility—not urgency—decides which companies investors trust to scale.
In a first for the U.S., Utah is letting artificial intelligence — not a doctor — renew certain medical prescriptions. No ...
Investing.com -- Aclarion Inc (NASDAQ:ACON) stock surged 43.7% in premarket trading Thursday after the healthcare technology company reported strong growth in scan volumes for its Nociscan platform, ...
Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...
Quarterly Nociscan scan volumes increased 114% year-over-year in Q4 2025Annual Nociscan scan volumes increased 69% year-over-year in 2025Debt-free balance sheet with $12.0 million in cash as of Decemb ...
Prevention may be the most effective response. Teaching young people how manipulation works could make them less susceptible.
InvestorsHub on MSN
Aclarion shares surge after sharp rise in Q4 Nociscan usage
Shares of Aclarion Inc (NASDAQ:ACON) jumped 43.7% in premarket trading on Thursday after the healthcare technology company ...
Once-weekly TransCon® CNP and TransCon® hGH combination therapy showed durable growth without compromising safety or tolerability at 52 weeks– ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback